Due to the Network Pharmacology Analysis on SJZD and the data analysis of 13 common targets DEGs, the therapeutic mechanism of SJZD against GC was shown to associate with STAT3 via JAK-STAT pathway. Here, STAT3 is linked to gastric cancer.